Columbia Trust’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-2,531
Closed -$698K 130
2023
Q1
$698K Hold
2,531
0.4% 70
2022
Q4
$980K Hold
2,531
0.55% 55
2022
Q3
$605K Sell
2,531
-100
-4% -$26.8K 0.34% 76
2022
Q2
$586K Sell
2,631
-150
-5% -$64.5K 0.31% 79
2022
Q1
$1.83M Sell
2,781
-676
-20% -$407K 0.86% 31
2021
Q4
$2.56M Hold
3,457
1.36% 14
2021
Q3
$2.56M Sell
3,457
-613
-15% -$418K 1.35% 14
2021
Q2
$3.05M Sell
4,070
-1,030
-20% -$787K 1.74% 10
2021
Q1
$4.16M Buy
+5,100
New +$3.93M 2.58% 6

Other funds holding OM

Columbia Trust's OM Position: Q2 2023 in Review

Columbia Trust sold out of Outset Medical (OM) in Q2 2023, closing a stake of 2,531 shares — an estimated $698K sold.

Columbia Trust first reported a position in OM in Q1 2021 and held it in 9 quarters. The position peaked at $4.16M in Q1 2021. 154 funds tracked by Wall St. Rank hold OM as of Q2 2023.

  • Columbia Trust reported no remaining Outset Medical position as of Q2 2023 after selling out during the quarter.
  • Columbia Trust sold 2,531 Outset Medical shares in Q2 2023, an estimated $698K.
  • Columbia Trust first reported a position in Outset Medical in Q1 2021 and held it in 9 quarters.
  • Columbia Trust's Outset Medical position peaked at $4.16M in Q1 2021.
  • 154 funds tracked by Wall St. Rank held Outset Medical as of Q2 2023.

Based on Columbia Trust's 13F filing for Q2 2023, filed 18 Jul 2023.